UB Paderborn / Katalog / Suche / in CDI

PD‐1 and PD‐L1 expression in HNSCC primary cancer and related lymph node metastasis – impact on clinical outcome

Histopathology, 2018-10, Vol.73 (4), p.573-584

2018

Volltextzugriff (PDF)

Immuntherapie in der Onkologie

Wiener klinische Wochenschrift Education, 2017-12, Vol.12 (1-4), p.17-33

Füreder, Thorsten

2017

Volltextzugriff (PDF)

Molecularly guided treatment of metastatic parotid gland carcinoma in adults

Wiener Klinische Wochenschrift, 2021-01, Vol.133 (1-2), p.32-40

2021

Volltextzugriff (PDF)

Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer

Head & neck, 2013-10, Vol.35 (10), p.1471-1474

2013

Volltextzugriff (PDF)

Head and neck cancer revisited

Memo - Magazine of European medical oncology, 2023-09, Vol.16 (3), p.146-147

Füreder, Thorsten

2023

Volltextzugriff (PDF)

The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils

PloS one, 2012-01, Vol.7 (1), p.e29925

2012

Volltextzugriff (PDF)

Immunotherapy revisited

Memo - Magazine of European medical oncology, 2021-06, Vol.14 (2), p.127-128

Füreder, Thorsten

2021

Volltextzugriff (PDF)

A Cross-Sectional Study of Patients' Satisfaction With Totally Implanted Access Ports

Clinical journal of oncology nursing, 2016-04, Vol.20 (2), p.175

2016

Volltextzugriff (PDF)

Review of cancer treatment with immune checkpoint inhibitors: Current concepts, expectations, limitations and pitfalls

Wiener Klinische Wochenschrift, 2018-02, Vol.130 (3-4), p.85-91

2018

Volltextzugriff (PDF)

Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial

European journal of cancer (1990), 2021-07, Vol.151, p.201-210

2021

Volltextzugriff (PDF)

Affective temperament, fatigue, and pain in cancer patients

Journal of affective disorders, 2023-11, Vol.340, p.80-87

2023

Volltextzugriff (PDF)

An analysis of distant metastasis cases from HPV-associated oropharyngeal squamous cell carcinoma

Journal of cranio-maxillo-facial surgery, 2021-04, Vol.49 (4), p.312-316

2021

Volltextzugriff (PDF)

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of the AGMT

Wiener Klinische Wochenschrift, 2021-11, Vol.133 (21-22), p.1131-1136

2021

Volltextzugriff (PDF)

The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients

International journal of clinical and health psychology, 2023-10, Vol.23 (4), p.100404-100404, Article 100404

2023

Volltextzugriff (PDF)

Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction

Memo - Magazine of European medical oncology, 2020, Vol.13 (3), p.245-246

2020

Volltextzugriff (PDF)

Abstract 2151: Identification of transcript adenosine fingerprint to enrich for A2AR and PD-1 inhibition responders

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2151-2151

2023

Volltextzugriff (PDF)

Kolorektalkarzinom

Wiener klinische Wochenschrift Education, 2012-12, Vol.7 (2), p.77-91

2012

Volltextzugriff (PDF)

Abstract 4150: Enriching for adenosine antagonist patient responses through deep learning

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.4150-4150

2022

Volltextzugriff (PDF)

Abstract 1893: Deep learning supported high content analysis of primary patient samples identifies ALK inhibition as a novel mechanism of action in a subset of ovarian cancers

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1893-1893

2022

Volltextzugriff (PDF)

Ercc1 Expression is Associated with Response to Gemox Plus Erlotinib in Pancreatic Adenocarcinoma Patients

Annals of oncology, 2013-06, Vol.24, p.iv80-iv80

2013

Volltextzugriff (PDF)

Abstract 4956: Discovering novel targetable pathways by combining functional and multi-omic data from primary ovarian cancer samples

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4956-4956

2023

Volltextzugriff (PDF)

Therapie des kastrationsrefraktären Prostatakarzinoms

Wiener Klinische Wochenschrift, 2012-08, Vol.124 (15-16), p.538-551

2012

Volltextzugriff (PDF)

Abstract 4081: Sensitivity of gastric cancer cell lines against 2-deoxy-D-glucose is independent of PI3K/mTOR inhibition

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4081-4081

2011

Volltextzugriff (PDF)

Abstract 4470: The dual PI3K/mTOR inhibitor BEZ235 impairs gastric cancer growth in vitro and in vivo

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4470-4470

2010

Volltextzugriff (PDF)

Abstract A124: ERCC1 expression correlates with EGFR expression and is regulated by cisplatin, cetuximab, and dasatinib in head and neck cancer cells

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.A124-A124

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

PD‐1 and PD‐L1 expression in HNSCC primary cancer and related lymph node metastasis – impact on clinical outcome

Immuntherapie in der Onkologie

Molecularly guided treatment of metastatic parotid gland carcinoma in adults

Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer

Head and neck cancer revisited

The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils

Immunotherapy revisited

A Cross-Sectional Study of Patients' Satisfaction With Totally Implanted Access Ports

Review of cancer treatment with immune checkpoint inhibitors: Current concepts, expectations, limitations and pitfalls

Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial

Affective temperament, fatigue, and pain in cancer patients

An analysis of distant metastasis cases from HPV-associated oropharyngeal squamous cell carcinoma

Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone: Analysis of the Austrian head and neck cancer registry of the AGMT

The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients

Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction

Abstract 2151: Identification of transcript adenosine fingerprint to enrich for A2AR and PD-1 inhibition responders

Kolorektalkarzinom

Abstract 4150: Enriching for adenosine antagonist patient responses through deep learning

Abstract 1893: Deep learning supported high content analysis of primary patient samples identifies ALK inhibition as a novel mechanism of action in a subset of ovarian cancers

Ercc1 Expression is Associated with Response to Gemox Plus Erlotinib in Pancreatic Adenocarcinoma Patients

Abstract 4956: Discovering novel targetable pathways by combining functional and multi-omic data from primary ovarian cancer samples

Therapie des kastrationsrefraktären Prostatakarzinoms

Abstract 4081: Sensitivity of gastric cancer cell lines against 2-deoxy-D-glucose is independent of PI3K/mTOR inhibition

Abstract 4470: The dual PI3K/mTOR inhibitor BEZ235 impairs gastric cancer growth in vitro and in vivo

Abstract A124: ERCC1 expression correlates with EGFR expression and is regulated by cisplatin, cetuximab, and dasatinib in head and neck cancer cells

Suchergebnisse filtern